Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-25-01660
Affiliations:
11
Authors:
23
Go to article
Institutions Authors Share
IRCCS European Institute of Oncology (IEO), Italy
9.200000
 0.40
University of Milan (UNIMI), Italy
5.200000
 0.23
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
2.866667
 0.12
University of Milano-Bicocca (UNIMIB), Italy
2.000000
 0.09
Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), United States of America (USA)
1.366667
 0.06
Harvard Medical School (HMS), United States of America (USA)
1.166667
 0.05
Humanitas Gavazzeni, Italy
1.000000
 0.04
Harvard University, United States of America (USA)
0.200000
 0.01
Interested in Oncology and Carcinogenesis?